TRANSL PSYCHIAT 润色咨询

Translational Psychiatry

出版年份:暂无数据 年文章数:321 投稿命中率:50.0%

出版周期:Monthly 自引率:3.9% 审稿周期:平均1.67月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均1.67月 (网友贡献,非官方数据)
投稿命中率
50.0% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量10.59% (2018年为9.72%)
自引率
3.9 %
年文章数
321
期刊官网
点击查看 (点击次数:4257)
点击查看 (点击次数:2277次)
作者需知
点击查看 (点击次数:381次)
期刊简介
稿件收录要求

Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.

Journal metrics

The 2018 journal metrics* for Translational Psychiatry are as follows:

  • 2-year impact factor: 5.182
  • 5-year impact factor: 5.681
  • Immediacy index: 0.745
  • Eigenfactor ® score: 0.02486
  • Article influence score: 1.822
  • Rank: 18/146 in Psychiatry
打开APP